<DOC>
	<DOCNO>NCT02767882</DOCNO>
	<brief_summary>The primary aim total knee replacement improvement functional activity reduce pain due degenerate knee joint . However , around 20-30 % patient would develop significant pain problem despite uncomplicated total knee replacement . It account major post-operative problem burden . Dexamethasone glucocorticoid associate anti-inflammatory response . It well know prophylaxis effect post-operative nausea vomit . Perioperative single dose systemic dexamethasone show useful reduction pain cumulative opioid consumption . Meta-analysis De Oliveira et al support dexamethasone ( 0.2 mg/kg ) safe effective multimodal pain strategy surgical procedure . However , dose recommendation surgery specific . It essential RCTs evaluate optimal dose steroid pain management hip knee surgery .</brief_summary>
	<brief_title>Dexamethasone Pain Control After Total Knee Replacement</brief_title>
	<detailed_description>Patients approach preadmission clinic general ward operation . The analgesic method explain s/he recruit study s/he agree . There standardized preoperative , intraoperative postoperative analgesic regime patient undergo total knee replacement . For preoperative analgesic regime , pregabalin 50mg give night operation . Same analgesic regime use day operation . For intraoperative regime , standardize intraarticular local anaesthetic infiltration use . For postoperative analgesic regime , PCA use morphine use . In addition PCA use morphine , standardize analgesic regime use -- regular pregabalin 50mg nocte , paracetmal 1g QID , Celebrex 200mg BD give 5 day . Patients randomize one three group . Patients first group ( D1 ) receive standardize oral analgesic regime pre-operatively , intraoperatively postoperatively . In addition , give preoperative intravenous 8mg dexamethasone . Patients second ( D2 ) group give preoperative intravenous 16mg dexamethasone , addition pre-operative , intraoperative post-operative analgesic regime . Patients third ( C ) group give preoperative intravenous 4ml 0.9 % saline , addition pre-operative , intraoperative post-operative analgesic regime . Preoperative Care Assessment do preadmission clinic general ward . Pre-operative pregabalin give operation day operation . Fasting start six hour operation . Range movement operate knee , quadriceps function , pain score affect knee assess day operation . Pre-operative inflammatory marker ( e.g . CRP , ESR , tumour necrosis factor α , interleukin IL-6 ) H'stix take day admission . Anaesthetic intraoperative care All patient anaesthetize accord follow protocol : On arrival operation theatre , 18 16 gauge intravenous cannula insert . Standard monitoring pulse oximeter , non-invasive blood pressure , three lead electrocardiogram apply prior induction . Non-invasive blood pressure check least every 5 minute throughout operation . Patients provide spinal anaesthesia operation 2.4 ml 0.5 % heavy Marcaine administrate spinal space position confirm spinal needle . No intrathecal opioid give procedure . Patient sedate TCI propofol ( 0.3 -1 ug/ml ) throughout whole total knee replacement successful spinal anaesthesia . Intravenous antibiotic give skin incision . Hypotension manage intravenous phenylephrine ephedrine discretion anaesthesiologist . Intra-operative fluid 8-10ml/kg/hr infused maintenance . Also intravenous bolus fluid give replacement blood loss . Infusion fluid warm thermal blanket use aim keep core temperature 35.5-37.5 degree Celsius . Local anaesthetic infiltration 40ml 0.75 % ropivacaine , 0.5ml 1:200,000 adrenaline , 30mg ketorolac 60ml normal saline administrate orthopaedic surgeon implant insertion wound closure . Patients subsequently transfer post anaesthetic care unit ( PACU ) monitoring least 1 hour . H'stix H'cue check 2 hour 4 hour preoperative injection dexamethasone . Analgesic modality pain assessment Procedures analgesic modality describe : Group D1 Patients group D give bolus injection 2 ml saline 2 ml dexamethasone ( 4mg/ml ) skin incision . Group D2 4ml bolus injection dexamethasone ( 4mg/ml ) give intravenously prior incision . Group C 4ml bolus injection 0.9 % saline give intravenously prior incision . For group In recovery room surgery , boluses 2mg intravenous morphine give every 5 minute numerical rating pain score ( NRS ) less 4/10 . A PCA machine connect . The machine configure give 1mg morphine time lockout duration set 5 minute . No background infusion give maximum dose limit 0.1mg/kg per hour morphine sulphate . Intramuscular morphine sulphate dose 0.1mg/kg prescribed every 4 hour necessary breakthrough begin postoperative day 0 . Intravenous 4mg ondansetron use every 4 hour necessary nausea vomit . On postoperative day 0 , patient resume oral diet contraindicate . Oral paracetamol COX-2 inhibitor give 5 day . Oral pregabalin give 7 day . While PCA morphine , patient 's respiratory rate , SpO2 sedation score monitor every hour . Heart rate blood pressure check every 4 hour . NRS pain score rest , knee movement , sleep , cumulative PCA morphine dos , number PCA demands/goods deliver , side effect ( nausea , vomit , dizziness ) record every 4 hour . Patients assess pain team everyday . Patients PCA morphine least 2 day . If NRS pain score knee movement postoperative day 2 less 4/10 clinically low morphine consumption , PCA morphine stop . PCA morphine continue NRS equal great 4 , patient remain high PCA consumption . After PCA morphine stop , NRS pain score rest knee movement , well dose frequency rescue analgesia use chart day discharge . Surgical technique/Prosthesis The surgery perform surgical team standardize surgical technique . All patient posterior stabilize knee prosthesis . Tranexamic acid give accord protocol . Standardized regimen technique local infiltration analgesic end surgery give part multi-modal pain control protocol Postoperative care assessment Day zero mobilization early mobilization PT OT rehabilitation encourage operation . Fluid diet allow postoperative day 0 . The surgical team ass occurrence postoperative surgical complication , suitability discharge ( good pain control , ambulation , normal bowel function , ability eat properly without vomit . Urinary retention document well . Range movement operate knee rehabilitation parameter assessment allied health staff Day 0 till day discharge . Side effect steroid document e.g . gastrointestinal bleeding , hyperglycaemia , wound infection ( Southampton wound assessment scale ) , systemic infection document . Glucose level measure 7am 5pm Day 1 Day 2 . Insulin use keep glucose &lt; 15 mmol/dl . Blood investigation also perform . Inflammatory marker e.g . ESR , CRF , tumour necrosis factor α , interleukin IL-6 take Day 0 , Day 1 Day 2 . Haemoglobin level need transfusion document .</detailed_description>
	<mesh_term>Acute Pain</mesh_term>
	<mesh_term>Dexamethasone acetate</mesh_term>
	<mesh_term>Dexamethasone</mesh_term>
	<mesh_term>Dexamethasone 21-phosphate</mesh_term>
	<mesh_term>BB 1101</mesh_term>
	<criteria>ASA IIII Age 1880 year old Scheduled elective primary unilateral total knee replacement Chinese patient Able speak understand Cantonese Able provide inform oral write consent Revision total knee replacement Single stage bilateral total knee replacement Known allergy opioids , local anaesthetic drug , paracetamol , nonsteroidal antiinflammatory drug ( NSAIDS ) include COX2 inhibitor History chronic pain chronic knee pain History insulin dependent diabetic mellitus , diabetic mellitus oral hyperglycaemic agent History hepatitis B C carrier History peptic ulcer Hx tuberculosis History immunosuppression Daily use glucocorticoid Daily use strong opioids ( morphine , fentanyl , hydromorphone , ketobemidone , methadone , nicomorphine , oxycodone , meperidine ) History severe heart disease ( NYHA 2 ) Alcohol drug abuse Impaired renal function , define preoperative serum creatinine level 120micromol/L Preexisting neurological muscular disorder Psychiatric illness neurologic psychiatric disease potentially influence pain perception Impaired retard mental state Difficulties use patient control analgesia ( PCA ) Pregnancy Local infection On immunosuppresants Patient refusal</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>May 2016</verification_date>
</DOC>